# Intervention to End Recurrent Unscheduled Bleeding Trial

> **NCT03118297** · PHASE3 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 65 (actual)

## Conditions studied

- Contraception
- Bleeding

## Interventions

- **DRUG:** Ulipristal Acetate
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03118297
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-01
- **Primary completion:** 2018-01-31
- **Final completion:** 2018-01-31
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2018-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03118297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03118297, "Intervention to End Recurrent Unscheduled Bleeding Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03118297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*